Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Melanoma complicating treatment with natalizumab for multiple sclerosis.
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study.
Dimethyl fumarate - only an anti-psoriatic medication?
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
UCSF Neuroimmunology Seminar
The CSF JCV antibody index for diagnosis of natalizumab-associated PML.
CCR2+CCR5+ T Cells Producing Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis.
Tonic spasms are a common clinical manifestation in patients with neuromyelitis optica.
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Biomarkers of treatment response in multiple sclerosis.
Simvastatin affects cell motility and actin cytoskeleton distribution of microglia.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
Lower physical activity is associated with higher disease burden in pediatric multiple sclerosis.
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.
Evidence for a two-stage disability progression in multiple sclerosis.
Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
The role of endogenous antiradical protective system in multiple sclerosis.
Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis.
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
[Interferon-β1b in multiple sclerosis therapy : More than 20 years clinical experience.]

Pages